The pharmacokinetics/pharmacodynamic relationship of durlobactam in combination with sulbactam in in vitro and in vivo infection model systems versus …

JP O'Donnell, SM Bhavnani - Clinical Infectious Diseases, 2023 - academic.oup.com
Sulbactam-durlobactam is a β-lactam/β-lactamase inhibitor combination currently in
development for the treatment of infections caused by Acinetobacter, including multidrug …
被引用次数：8 相关文章

The Pharmacokinetics/Pharmacodynamic Relationship of Durlobactam in Combination With Sulbactam in In Vitro and In Vivo Infection Model Systems Versus …

JP O'Donnell, SM Bhavnani - Clinical infectious diseases …, 2023 - pubmed.ncbi.nlm.nih.gov
Sulbactam-durlobactam is a β-lactam/β-lactamase inhibitor combination currently in
development for the treatment of infections caused by Acinetobacter, including multidrug …

The Pharmacokinetics/Pharmacodynamic Relationship of Durlobactam in Combination With Sulbactam in In Vitro and In Vivo Infection Model Systems Versus …

JP O'Donnell, SM Bhavnani - … Diseases: an Official Publication of the …, 2023 - europepmc.org
Sulbactam-durlobactam is a β-lactam/β-lactamase inhibitor combination currently in
development for the treatment of infections caused by Acinetobacter, including multidrug …
[HTML] nih.gov

[HTML][HTML] The Pharmacokinetics/Pharmacodynamic Relationship of Durlobactam in Combination With Sulbactam in In Vitro and In Vivo Infection Model Systems Versus …

JP O'Donnell, SM Bhavnani - … of the Infectious Diseases Society of …, 2023 - ncbi.nlm.nih.gov
Sulbactam-durlobactam is a β-lactam/β-lactamase inhibitor combination currently in
development for the treatment of infections caused by Acinetobacter, including multidrug …
[PDF] semanticscholar.org

[PDF][PDF] The Pharmacokinetics/Pharmacodynamic Relationship of Durlobactam in Combination With Sulbactam in In Vitro and In Vivo Infection Model Systems Versus …

JP O'Donnell, SM Bhavnani - Clinical Infectious Diseases, 2023 - pdfs.semanticscholar.org
Sulbactam-durlobactam is a β-lactam/β-lactamase inhibitor combination currently in
development for the treatment of infections caused by Acinetobacter, including multidrug …

The pharmacokinetics/pharmacodynamic relationship of durlobactam in combination with sulbactam in in vitro and in vivo infection model systems versus …

JP O'Donnell, SM Bhavnani - 2023 - cabidigitallibrary.org
Sulbactam-durlobactam is a β-lactam/β-lactamase inhibitor combination currently in
development for the treatment of infections caused by Acinetobacter, including multidrug …

The Pharmacokinetics/Pharmacodynamic Relationship of Durlobactam in Combination With Sulbactam in In Vitro and In Vivo Infection Model Systems Versus …

JP O'Donnell, SM Bhavnani - … Diseases: an Official Publication of the …, 2023 - europepmc.org
Sulbactam-durlobactam is a β-lactam/β-lactamase inhibitor combination currently in
development for the treatment of infections caused by Acinetobacter, including multidrug …